Wisconsin Researchers Participate in Alzheimer's Breakthrough Ride
Follow the Ride
Alzheimer's Breakthrough Ride Blog
Show Your Support
Sign the Petition at the Alzheimer's Breakthrough Ride Website
Department of Medicine
Geriatrics - UW Health
Two researchers from the University of Wisconsin School of Medicine and Public Health in Madison participated in a cross-country bike ride to promote awareness of Alzheimer's disease.
Barbara Bendlin, PhD, and Michele Ries, PhD, researchers at the Wisconsin Alzheimer's Disease Research Center, are among 55 scientists cycling in the Alzheimer's Breakthrough Ride, a bike tour from San Francisco to Washington, D.C., that will culminate with the presentation of a petition urging lawmakers to make Alzheimer's disease a national priority.
On September 1, Bendlin and Ries embarked on a two-day ride from Madison to Chicago, covering about 150 miles. Along the way, they collected signatures for the petition and shared updates from the road via the Alzheimer's Breakthrough Ride Blog.
Watch the video below to learn about their participation in the ride.
The Wisconsin researchers' segment of the ride was preceded by a petition signing event in Madison, which was held at the State Capitol.
The Alzheimer's Breakthrough Ride began on July 17 in San Francisco and will finish on September 21 in the nation's capital, where the petition will be presented to Congress.
The ride was originally conceived by Alzheimer's disease researcher Bruce Lamb, PhD, of the Cleveland Clinic and Case Western Reserve University.
During a casual bike ride last summer, Lamb pondered the difficulties in getting adequate federal funding for Alzheimer's research and became convinced that researchers needed to do even more to fight the disease. He shared the idea of a cross-country bike ride to build support for Alzheimer's with the Alzheimer's Association.
The Wisconsin Alzheimer's Disease Research Center is a collaboration between the UW School of Medicine and Public Health and the Geriatric Research, Education, and Clinical Center (GRECC) of the William S. Middleton Memorial Veterans Hospital.
The center's focus is to investigate ways to distinguish normal aging from abnormal cognitive decline, to identify people at risk for Alzheimer's disease before any symptoms of memory loss occur, and to find effective treatments to prevent or delay the onset and progression of Alzheimer's.
Date Published: 08/25/2010